17:57 Minutes Lung Cancer Expression Exchange (LCEE) 1st Aug 2024-5Y Pooled Analysis: Unveiling the Non-Expression in NSCLC by Dr Tan Chee Seng Overview 5-Year Follow-up Pooled Analysis for metastatic NSCLC with PD-L1 TPS <1% BACK TO WEBCASTS MY-LAM-00137 Oct/2024
52:59 Minutes - 2 Chapters 1L Advanced Esophageal Cancer: Entering a New Survival Horizon BACK TO WEBCASTS MY-PDO-00044 Oct/2024
13:41 Minutes Evolving Treatment Landscape in Esophageal Cancer and Current Unmet Need Overview: Dr John Low provides a comprehensive overview on the evolving treatment landscape of esophageal cancer. NEXT VIDEO BACK TO […]
66:18 Minutes - 4 Chapters Unlocking New Paradigm in the Treatment of Metastatic TNBC BACK TO WEBCASTS MY-OBR-00021 Apr/2022
42:16 Minutes - 3 Chapters Personalizing Treatment of M/uR HNSCC with Immune Checkpoint Inhibitor BACK TO WEBCASTS MY-OHN-00015 Sep/2024
35:00 Minutes - 3 Chapters Redefining Survival Expectation for Relapsed or Refractory Classical Hodgkin Lymphoma
37 Minutes - 4 Chapters What Have We Learned in 2019 on Combination Treatments for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) BACK TO WEBCASTS MY-KEY-00210 02/20
43 Minutes - 1 Chapter Redefining Survival with IO-TKI Strategy in Renal Cell Carcinoma (RCC) Overview The emergence of IO-TKI combination therapy has redefined survival expectations in advanced RCC. Professor Brian Rini provides a comprehensive […]
51 Minutes - 2 Chapters Pembrolizumab in Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) BACK TO WEBCASTS MY-KEY-00147 09/19
31 Minutes - 4 Chapters Post WCLC and ESMO 2019 Update: Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) BACK TO WEBCASTS MY-KEY-00155 10/19